S. Sim
Pharmacology · with Ingelman-Sundberg · 2006–2007
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Pharmacology — 17 citations into it
- Oncology — 8 citations into it
Whom S. Sim trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts S. Sim overall
Papers from S. Sim's perspective
Ordered by how strongly the researchers S. Sim trusts endorse each paper. Same corpus, a different order for every researcher.
- Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response (Molecular Psychiatry)
- Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism (Clinical Pharmacokinetics)
- The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution (Science)
- Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs (Nature)
- Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression (Nature Genetics)
- Relative impact of nucleotide and copy number variation on gene expression phenotypes (Science)
- Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity (The Pharmacogenomics Journal)
- Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. (TIPS - Trends in Pharmacological Sciences)
- Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. (The Lancet)
- Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR‐1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus (Clinical pharmacology and therapy)
Their papers
- Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects. (2007) — 1,166 citations
- A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants (2006) — 778 citations